These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31309498)

  • 1. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.
    Armbruster CE; Mobley HL
    Nat Rev Microbiol; 2012 Nov; 10(11):743-54. PubMed ID: 23042564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
    Norsworthy AN; Pearson MM
    Trends Microbiol; 2017 Apr; 25(4):304-315. PubMed ID: 28017513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteus mirabilis and Urinary Tract Infections.
    Schaffer JN; Pearson MM
    Microbiol Spectr; 2015 Oct; 3(5):. PubMed ID: 26542036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Opportunist,
    Learman BS; Brauer AL; Eaton KA; Armbruster CE
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteus mirabilis biofilms and catheter-associated urinary tract infections.
    Jacobsen SM; Shirtliff ME
    Virulence; 2011; 2(5):460-5. PubMed ID: 21921687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swarming and pathogenicity of Proteus mirabilis in the urinary tract.
    Mobley HL; Belas R
    Trends Microbiol; 1995 Jul; 3(7):280-4. PubMed ID: 7551643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of urolithiasis and bacteremia during Proteus mirabilis and Providencia stuartii coinfection due to synergistic induction of urease activity.
    Armbruster CE; Smith SN; Yep A; Mobley HL
    J Infect Dis; 2014 May; 209(10):1524-32. PubMed ID: 24280366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
    [No Abstract]   [Full Text] [Related]  

  • 17. Indwelling Urinary Catheter Model of Proteus mirabilis Infection.
    Smith SN; Armbruster CE
    Methods Mol Biol; 2019; 2021():187-200. PubMed ID: 31309506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control.
    Broomfield RJ; Morgan SD; Khan A; Stickler DJ
    J Med Microbiol; 2009 Oct; 58(Pt 10):1367-1375. PubMed ID: 19556373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
    White AN; Learman BS; Brauer AL; Armbruster CE
    Infect Immun; 2021 Sep; 89(10):e0017721. PubMed ID: 34280035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL; Chippendale GR
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.